336 related articles for article (PubMed ID: 32421442)
1. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol.
Hiyama E; Hishiki T; Watanabe K; Ida K; Ueda Y; Kurihara S; Yano M; Hoshino K; Yokoi A; Takama Y; Nogami Y; Taguchi T; Mori M; Kihira K; Miyazaki O; Fuji H; Honda S; Iehara T; Kazama T; Fujimura J; Tanaka Y; Inoue T; Tajiri T; Kondo S; Oue T; Yoshimura K
J Clin Oncol; 2020 Aug; 38(22):2488-2498. PubMed ID: 32421442
[TBL] [Abstract][Full Text] [Related]
2. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
Hishiki T; Matsunaga T; Sasaki F; Yano M; Ida K; Horie H; Kondo S; Watanabe K; Oue T; Tajiri T; Kamimatsuse A; Ohnuma N; Hiyama E
Pediatr Surg Int; 2011 Jan; 27(1):1-8. PubMed ID: 20922397
[TBL] [Abstract][Full Text] [Related]
3. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
4. Surgical strategies for unresectable hepatoblastomas.
Tajiri T; Kimura O; Fumino S; Furukawa T; Iehara T; Souzaki R; Kinoshita Y; Koga Y; Suminoe A; Hara T; Kohashi K; Oda Y; Hishiki T; Hosoi H; Hiyama E; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2194-8. PubMed ID: 23217875
[TBL] [Abstract][Full Text] [Related]
5. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
Sasaki F; Matsunaga T; Iwafuchi M; Hayashi Y; Ohkawa H; Ohira M; Okamatsu T; Sugito T; Tsuchida Y; Toyosaka A; Nagahara N; Nishihira H; Hata Y; Uchino J; Misugi K; Ohnuma N;
J Pediatr Surg; 2002 Jun; 37(6):851-6. PubMed ID: 12037748
[TBL] [Abstract][Full Text] [Related]
6. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
[TBL] [Abstract][Full Text] [Related]
7. A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT).
Hiyama E; Ueda Y; Onitake Y; Kurihara S; Watanabe K; Hishiki T; Tajiri T; Ida K; Yano M; Kondo S; Oue T;
Pediatr Surg Int; 2013 Oct; 29(10):1071-5. PubMed ID: 24026876
[TBL] [Abstract][Full Text] [Related]
8. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Hiyama E; Hishiki T; Watanabe K; Ida K; Yano M; Oue T; Iehara T; Hoshino K; Koh K; Tanaka Y; Kurihara S; Ueda Y; Onitake Y
J Pediatr Surg; 2016 Dec; 51(12):2053-2057. PubMed ID: 27712887
[TBL] [Abstract][Full Text] [Related]
9. Mortality and morbidity in primarily resected hepatoblastomas in Japan: Experience of the JPLT (Japanese Study Group for Pediatric Liver Tumor) trials.
Hiyama E; Hishiki T; Watanabe K; Ida K; Yano M; Oue T; Iehara T; Hoshino K; Koh K; Tanaka Y; Kurihara S; Ueda Y; Onitake Y
J Pediatr Surg; 2015 Dec; 50(12):2098-101. PubMed ID: 26388131
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
11. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
Zsiros J; Brugieres L; Brock P; Roebuck D; Maibach R; Zimmermann A; Childs M; Pariente D; Laithier V; Otte JB; Branchereau S; Aronson D; Rangaswami A; Ronghe M; Casanova M; Sullivan M; Morland B; Czauderna P; Perilongo G;
Lancet Oncol; 2013 Aug; 14(9):834-42. PubMed ID: 23831416
[TBL] [Abstract][Full Text] [Related]
12. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
[TBL] [Abstract][Full Text] [Related]
13. [Strategy for the treatment of hepatoblastoma in children].
Sasaki F
Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):427-30. PubMed ID: 16045186
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
[TBL] [Abstract][Full Text] [Related]
15. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
Becker K; Furch C; Schmid I; von Schweinitz D; Häberle B
Pediatr Blood Cancer; 2015 Jan; 62(1):24-8. PubMed ID: 25251521
[TBL] [Abstract][Full Text] [Related]
16. New concepts and outcomes for children with hepatoblastoma based on the experience of a tertiary center over the last 21 years.
Tannuri AC; Cristofani LM; Teixeira RA; Odone Filho V; Tannuri U
Clinics (Sao Paulo); 2015 Jun; 70(6):387-92. PubMed ID: 26106955
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
[TBL] [Abstract][Full Text] [Related]
18. The Role Of Surgical Treatment In The Multidisciplinary Therapy For Hepatoblastoma.
Yada K; Ishibashi H; Mori H; Sato H; Shimada M
Hepatogastroenterology; 2014 May; 61(131):553-6. PubMed ID: 26176034
[TBL] [Abstract][Full Text] [Related]
19. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
[TBL] [Abstract][Full Text] [Related]
20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]